Skip to main content
Grafa
Teva signs global multiple sclerosis biosimilar agreement
Image for illustrative purposes only. Not a real photo.

Teva signs global multiple sclerosis biosimilar agreement

Share

Teva (NYSE:TEVA) signed a global licensing agreement with Polpharma Biologics for a proposed multiple sclerosis biosimilar.

More ways to discover

Browse United States newsDiscover NYSE signalsBrowse all NYSE stocksBrowse all NYSE ETFsExplore United States companiesFind the right NYSE index